These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Tumor necrosis factor promotes T-cell at the expense of B-cell lymphoid development from cultured human CD34+ cord blood cells. Smits K; De Smedt M; Naessens E; De Smet G; Stove V; Taghon T; Plum J; Verhasselt B Exp Hematol; 2007 Aug; 35(8):1272-8. PubMed ID: 17553612 [TBL] [Abstract][Full Text] [Related]
25. Apoptotic lymphocytes and CD34+ cells in cryopreserved cord blood detected by the fluorescent vital dye SYTO 16 and correlation with loss of L-selectin (CD62L) expression. Sparrow RL; Komodromou H; Tippett E; Georgakopoulos T; Xu W Bone Marrow Transplant; 2006 Jul; 38(1):61-7. PubMed ID: 16788684 [TBL] [Abstract][Full Text] [Related]
26. The effect of cryopreservation on clonogenic capacity and in vitro expansion potential of umbilical cord blood progenitor cells. Moezzi L; Pourfathollah AA; Alimoghaddam K; Soleimani M; Ardjmand AR Transplant Proc; 2005 Dec; 37(10):4500-3. PubMed ID: 16387154 [TBL] [Abstract][Full Text] [Related]
27. Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice. Fei XM; Wu YJ; Chang Z; Miao KR; Tang YH; Zhou XY; Wang LX; Pan QQ; Wang CY Cytotherapy; 2007; 9(4):338-47. PubMed ID: 17573609 [TBL] [Abstract][Full Text] [Related]
28. Peripheral blood and BM CD34+ CD38- cells show better resistance to cryopreservation than CD34+ CD38+ cells in autologous stem cell transplantation. Ojeda-Uribe M; Sovalat H; Bourderont D; Brunot A; Marr A; Lewandowski H; Chabouté V; Peter P; Henon P Cytotherapy; 2004; 6(6):571-83. PubMed ID: 15764022 [TBL] [Abstract][Full Text] [Related]
29. Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults. van Heeckeren WJ; Fanning LR; Meyerson HJ; Fu P; Lazarus HM; Cooper BW; Tse WW; Kindwall-Keller TL; Jaroscak J; Finney MR; Fox RM; Solchaga L; Forster M; Creger RJ; Laughlin MJ Br J Haematol; 2007 Nov; 139(3):464-74. PubMed ID: 17910637 [TBL] [Abstract][Full Text] [Related]
30. Quantification of progenitors capable of generating T cells in human cord blood. Kato M; Masuda K; Kakugawa K; Kawamoto H; Mugishima H; Katsura Y Eur J Haematol; 2008 Feb; 80(2):151-9. PubMed ID: 18005390 [TBL] [Abstract][Full Text] [Related]
31. Refreezing of cord blood hematopoietic stem cells for allogenic transplantation: in vitro and in vivo validation of a clinical phase I/II protocol in European and Italian Good Manufacturing Practice conditions. Gunetti M; Ferrero I; Rustichelli D; Berger M; Gammaitoni L; Timeus F; Piacibello W; Aglietta M; Fagioli F Exp Hematol; 2008 Feb; 36(2):235-43. PubMed ID: 18206730 [TBL] [Abstract][Full Text] [Related]
32. Impact of maternal and neonatal factors on CD34+ cell count, total nucleated cells, and volume of cord blood. Jan RH; Wen SH; Shyr MH; Chiang BL Pediatr Transplant; 2008 Dec; 12(8):868-73. PubMed ID: 18643913 [TBL] [Abstract][Full Text] [Related]
34. Multi-laboratory evaluation of procedures for reducing the volume of cord blood: influence on cell recoveries. Takahashi TA; Rebulla P; Armitage S; van Beckhoven J; Eichler H; Kekomäki R; Letowska M; Wahab F; Moroff G Cytotherapy; 2006; 8(3):254-64. PubMed ID: 16793734 [TBL] [Abstract][Full Text] [Related]
35. Study of hematopoietic progenitor cells, hematological values and lymphocyte subsets in cord blood: application for cord blood transplantation. Chaisiripoomkere W; Jootar S; Ungkanont A; Jaovisidha A; Onpun S; Khupulsup K Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):781-5. PubMed ID: 10928377 [TBL] [Abstract][Full Text] [Related]
36. Influence of delivery on numbers of leukocytes, leukocyte subpopulations, and hematopoietic progenitor cells in human umbilical cord blood. Lim FT; van Winsen L; Willemze R; Kanhai HH; Falkenburg JH Blood Cells; 1994; 20(2-3):547-58; discussion 558-9. PubMed ID: 7749120 [TBL] [Abstract][Full Text] [Related]
37. Association of cord blood platelet characteristics and hematopoietic progenitor cells. Eskola M; Rekunen S; Aroviita P; Möttönen S; Hiilesmaa V; Sainio S; Kekomäki R Transfusion; 2008 May; 48(5):884-92. PubMed ID: 18298598 [TBL] [Abstract][Full Text] [Related]
38. A comparison of the kinetics of nucleated cells and CD34+ cells in neonatal peripheral blood and cord blood. Kim JP; Lee YH; Lee YA; Kim YD Biol Blood Marrow Transplant; 2007 Apr; 13(4):478-85. PubMed ID: 17382254 [TBL] [Abstract][Full Text] [Related]
39. CD34(+) CD38(-) and CD34(+) HLA-DR(-) cells in BM stem cell grafts correlate with short-term engraftment but have no influence on long-term hematopoietic reconstitution after autologous transplantation. Zubair AC; Kao G; Daley H; Schott D; Freedman A; Ritz J Cytotherapy; 2006; 8(4):399-407. PubMed ID: 16923616 [TBL] [Abstract][Full Text] [Related]
40. The impact of mode of delivery and gestational age on cord blood hematopoietic stem/progenitor cells. Dimitriou H; Perdikogianni C; Stiakaki E; Vorgia P; Hatzidaki E; Kalmanti M Ann Hematol; 2006 Jun; 85(6):381-5. PubMed ID: 16534595 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]